Unlisted
| Company Name | (주)바이오시네틱스 |
| English Name | Bio-Synectics, Inc. |
| Business Reg. No. | 1058663304 |
| CEO | 김갑식 |
| Address | 서울특별시 금천구 가산디지털2로 184, 708호(가산동, 벽산디지털밸리 2차) |
| Industry | 의학 및 약학 연구개발업 |
| Industry Code | 70113 |
| Main Products | 나노의약품 및 소재, 약물전달시스템 |
| Established | 20040129 |
| Phone | 02-2113-1285 |
| Website | www.bio-synectics.com |
| Regular Employees | Contact |
| Corp. Reg. No. | 1101112943010 |
Venture Certified
| 신기술기업(고도기술수반산업) | 2005-05-06 ~ 2007-05-05 | 051122032100739 | 2005-05-06 |
| 기술평가보증기업(기금) | 2007-05-06 ~ 2008-05-05 | 20070201045 | 2005-05-06 |
| 기술평가보증기업(기금) | 2010-02-17 ~ 2012-02-16 | 20100100983 | 2005-05-06 |
| 기술평가보증기업(기금) | 2012-02-17 ~ 2014-02-16 | 20120101219 | 2005-05-06 |
| 기술평가보증기업(기금) | 2014-02-17 ~ 2016-02-16 | 20140101294 | 2005-05-06 |
| 벤처투자유형 | 2016-02-17 ~ 2018-02-16 | 20160300056 | 2005-05-06 |
| 벤처투자유형 | 2018-02-17 ~ 2020-02-16 | 20180300135 | 2005-05-06 |
| 벤처투자유형 | 2020-02-17 ~ 2022-02-16 | 20200300123 | 2005-05-06 |
| 벤처투자유형 | 2022-02-17 ~ 2025-02-16 | 20220316010061 | 2005-05-06 |
| 벤처투자유형 | 2025-02-17 ~ 2028-02-16 | 20250225010040 | 2005-05-06 |
| Revenue | 7.7B |
| Operating Profit | -4.3B |
| Net Profit | -4.3B |
| Total Assets | 6.4B |
| Total Liabilities | 9.4B |
| Total Equity | -3.0B |
Capital Erosion: Total equity is negative or below 50% of capital stock
Operating Loss: Op. profit -4B
| Name | Position | Role |
|---|---|---|
| 김갑식 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "서울특별시 금천구",
"ceo_name": "김갑식",
"certificate": [
{
"cert_number": "051122032100739",
"changes": "",
"disclosure_date": "2005-05-06",
"first_cert_date": "2005-05-06",
"no": "1",
"type": "신기술기업(고도기술수반산업)",
"valid_period": "2005-05-06 ~ 2007-05-05"
},
{
"cert_number": "20070201045",
"changes": "",
"disclosure_date": "2007-05-31",
"first_cert_date": "2005-05-06",
"no": "2",
"type": "기술평가보증기업(기금)",
"valid_period": "2007-05-06 ~ 2008-05-05"
},
{
"cert_number": "20100100983",
"changes": "",
"disclosure_date": "2010-02-17",
"first_cert_date": "2005-05-06",
"no": "3",
"type": "기술평가보증기업(기금)",
"valid_period": "2010-02-17 ~ 2012-02-16"
},
{
"cert_number": "20120101219",
"changes": "",
"disclosure_date": "2012-02-22",
"first_cert_date": "2005-05-06",
"no": "4",
"type": "기술평가보증기업(기금)",
"valid_period": "2012-02-17 ~ 2014-02-16"
},
{
"cert_number": "20140101294",
"changes": "",
"disclosure_date": "2014-02-17",
"first_cert_date": "2005-05-06",
"no": "5",
"type": "기술평가보증기업(기금)",
"valid_period": "2014-02-17 ~ 2016-02-16"
},
{
"cert_number": "20160300056",
"changes": "",
"disclosure_date": "2016-02-25",
"first_cert_date": "2005-05-06",
"no": "6",
"type": "벤처투자유형",
"valid_period": "2016-02-17 ~ 2018-02-16"
},
{
"cert_number": "20180300135",
"changes": "",
"disclosure_date": "2018-02-22",
"first_cert_date": "2005-05-06",
"no": "7",
"type": "벤처투자유형",
"valid_period": "2018-02-17 ~ 2020-02-16"
},
{
"cert_number": "20200300123",
"changes": "",
"disclosure_date": "2020-02-13",
"first_cert_date": "2005-05-06",
"no": "8",
"type": "벤처투자유형",
"valid_period": "2020-02-17 ~ 2022-02-16"
},
{
"cert_number": "20220316010061",
"changes": "",
"disclosure_date": "2022-03-16",
"first_cert_date": "2005-05-06",
"no": "9",
"type": "벤처투자유형",
"valid_period": "2022-02-17 ~ 2025-02-16"
},
{
"cert_number": "20250225010040",
"changes": "",
"disclosure_date": "2025-02-25",
"first_cert_date": "2005-05-06",
"no": "10",
"type": "벤처투자유형",
"valid_period": "2025-02-17 ~ 2028-02-16"
}
],
"company_name": "㈜바이오시네틱스",
"corp_no": "110111-*******",
"financials": {
"2022": {
"capital_stock": 1795338000,
"cost_of_sales": 335153000,
"current_assets": 477236000,
"current_liabilities": 243576000,
"gross_profit": 431486000,
"net_income": -434194000,
"net_income_bs": -434194000,
"non_current_assets": 163410000,
"non_current_liabilities": 697213000,
"non_operating_expenses": 4264000,
"non_operating_income": 1279000,
"operating_profit": -431209000,
"revenue": 766640000,
"sga_expenses": 862696000,
"total_assets": 640646000,
"total_equity": -300144000,
"total_liabilities": 940790000
}
},
"industry": "의학 및 약학 연구개발업",
"investment": [
{
"amount": "2,999,999,000",
"changes": "2,999,999,000",
"date": "2017-11-17"
},
{
"amount": "2,999,000,000",
"changes": "2,999,000,000",
"date": "2017-11-17"
},
{
"amount": "2,999,998,500",
"changes": "2,999,998,500",
"date": "2017-11-17"
},
{
"amount": "3,000,000,000",
"changes": "3,000,000,000",
"date": "2015-12-15"
}
],
"main_products": "나노의약품 및 소재, 약물전달시스템",
"phone": "02-2113-****",
"years": [
2022
]
}Data Quality: 4/10 | Primary Source: Venture System | Section Coverage: 7/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | DART | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| DART Financial | 2026-02-27 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |